Correlation Between ASTELLAS PHARMA and Bayer AG

Can any of the company-specific risk be diversified away by investing in both ASTELLAS PHARMA and Bayer AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ASTELLAS PHARMA and Bayer AG into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ASTELLAS PHARMA UNSPADR and Bayer AG NA, you can compare the effects of market volatilities on ASTELLAS PHARMA and Bayer AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ASTELLAS PHARMA with a short position of Bayer AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of ASTELLAS PHARMA and Bayer AG.

Diversification Opportunities for ASTELLAS PHARMA and Bayer AG

-0.26

Correlation Coefficient

ASTELLAS PHARMA  Bayer AG

Very good diversification

The 3 months correlation between ASTELLAS and Bayer is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding ASTELLAS PHARMA UNSPADR and Bayer AG NA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bayer AG NA and ASTELLAS PHARMA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ASTELLAS PHARMA UNSPADR are associated (or correlated) with Bayer AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bayer AG NA has no effect on the direction of ASTELLAS PHARMA i.e., ASTELLAS PHARMA and Bayer AG go up and down completely randomly.

Pair Corralation between ASTELLAS PHARMA and Bayer AG

Assuming the 90 days trading horizon ASTELLAS PHARMA is expected to generate 21.41 times less return on investment than Bayer AG. But when comparing it to its historical volatility, ASTELLAS PHARMA UNSPADR is 1.11 times less risky than Bayer AG. It trades about 0.01 of its potential returns per unit of risk. Bayer AG NA is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  2,143  in Bayer AG NA on April 21, 2025 and sell it today you would earn a total of  626.00  from holding Bayer AG NA or generate 29.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

ASTELLAS PHARMA UNSPADR  vs.  Bayer AG NA

ASTELLAS PHARMA UNSPADR

Risk-Adjusted Performance

Very Weak

Over the last 90 days ASTELLAS PHARMA UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, ASTELLAS PHARMA is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Bayer AG NA

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Bayer AG NA are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Bayer AG reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ASTELLAS PHARMA and Bayer AG

The main advantage of trading using opposite ASTELLAS PHARMA and Bayer AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ASTELLAS PHARMA position performs unexpectedly, Bayer AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bayer AG will offset losses from the drop in Bayer AG's long position.

The idea behind ASTELLAS PHARMA UNSPADR and Bayer AG NA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.